As reported, TNFR2 is highly expressed by CD4+Foxp3+ Tregs and is associated with the immunosuppressive activity of tumor-infiltrating Tregs (Chen et al., 2007; Nguyen and Ehrenstein, 2016). The gene discussed is CD4; the disease is neoplasm.